D'APICE, LUCIANA
 Distribuzione geografica
Continente #
NA - Nord America 237
AS - Asia 171
EU - Europa 83
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 496
Nazione #
US - Stati Uniti d'America 235
SG - Singapore 125
IT - Italia 31
CN - Cina 23
FI - Finlandia 19
NL - Olanda 17
KR - Corea 9
DE - Germania 4
GB - Regno Unito 3
HK - Hong Kong 2
KG - Kirghizistan 2
PA - Panama 2
TJ - Tagikistan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
FR - Francia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 496
Città #
Santa Clara 184
Singapore 72
Helsinki 19
Avellino 11
Seoul 9
Los Angeles 7
Marigliano 7
Rome 6
Boardman 5
Falkenstein 3
Naples 3
Ashburn 2
Beijing 2
Bishkek 2
Dushanbe 2
Hong Kong 2
Portsmouth 2
Aversa 1
Bologna 1
Forest City 1
Gabrovo 1
Guangzhou 1
Islamabad 1
Jeddah 1
Kunovice 1
Lima 1
Lisbon 1
Ljubljana 1
Manassas 1
Manila 1
Oxford 1
Panama City 1
Phnom Penh 1
Pomigliano d'Arco 1
Quito 1
São Paulo 1
Tel Aviv 1
Vienna 1
Vientiane 1
Totale 360
Nome #
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant 26
Distinct Antigen Delivery Systems Induce Dendritic Cells' Divergent Transcriptional Response: New Insights from a Comparative and Reproducible Computational Analysis. 23
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 22
300x100: Protagoniste per la ricerca 20
PEI-Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa 19
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 18
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assay 16
Boosting antigen-specific T cell activation with lipid-stabilized protein nanoaggregates 16
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 15
Give a selfie for women @CNR 14
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 13
ImmuNapoli 2019 13
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 12
A preliminary investigation on hydrogel disks imbibed with enriched transfersomes as promising tool to promote the cutaneous deposition of vaccine antigens 12
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 12
Alternative splicing in adhesion- and motility-related genes in breast cancer 11
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 11
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 11
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 10
HIV Vaccination: A Roadmap among Advancements and Concerns. 9
Filamentous bacteriophage: an antigen and gene delivery system 9
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 9
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 9
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 8
Design of cassette vectors permitting cloning of all types of human TCR variable alpha and beta regions 8
Review HIV Vaccination: A Roadmap among Advancements and Concerns 8
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 8
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 8
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 8
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 8
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 8
Investigation on alternative splicing in MCF-7 cells by RNA-Seq: identification and characterization of a new transcript of SEMA3F. 7
T cell receptors 7
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFN³ production by CD4+ T cells 7
ImmuNapoli 2016 7
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 7
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform. 7
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 6
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 6
Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages. 6
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 5
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 5
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 5
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 5
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 5
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 5
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 5
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 5
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 5
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 5
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 5
Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge 5
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 5
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 5
Identification of a new subset of cells exhibiting dendritic phenotypes in patients affected by breast proliferative disorders. 4
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 4
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 4
Massive-scale RNA-seq analysis of non ribosomal transcriptome in human Trisomy 21. 4
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 4
Massive-Scale RNA-Seq Analysis of Non Ribosomal Transcriptome in Human Trisomy 21 3
Massive-scale analysis of rRNA-depleted transcriptional landscape in human trisomy 21 3
RNA-seq: from computational challenges to biological insights 1
Totale 551
Categoria #
all - tutte 2.521
article - articoli 1.580
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 40
Totale 4.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202444 0 0 0 0 0 0 0 1 2 2 26 13
2024/2025507 7 4 74 37 194 37 10 91 36 17 0 0
Totale 551